Annual report

Period2023-01-01 → 2023-12-31
Filed2024-03-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 143
MetricValuePeriodScopeSource row
Revenue¥4.3bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥4.1bn2022-01-01 → 2022-12-31Cons.Net sales
Revenue¥3.4bn2021-01-01 → 2021-12-31dCons.Net sales (5-year summary)
Revenue¥2.9bn2020-01-01 → 2020-12-31dCons.Net sales (5-year summary)
Revenue¥2.4bn2019-01-01 → 2019-12-31dCons.Net sales (5-year summary)
Operating income¥111m2023-01-01 → 2023-12-31Cons.Operating income
Operating income¥194m2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income¥193m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥247m2022-01-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥188m2021-01-01 → 2021-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥135m2020-01-01 → 2020-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥107m2019-01-01 → 2019-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥193m2023-01-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥247m2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥127m2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥158m2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥138m2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥102m2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥77m2019-01-01 → 2019-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥127m2023-01-01 → 2023-12-31Cons.Profit loss
Net income¥158m2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥4.1bnat 2023-12-31Cons.Assets
Total assets¥3.0bnat 2022-12-31Cons.Assets
Total assets¥2.9bnat 2021-12-31dCons.Total assets (5-year summary)
Total assets¥2.1bnat 2020-12-31dCons.Total assets (5-year summary)
Total assets¥2.1bnat 2019-12-31dCons.Total assets (5-year summary)
Total liabilities¥2.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥1.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥1.1bnat 2022-12-31Cons.Net assets
Net assets / equity¥927mat 2021-12-31dCons.Net assets
Net assets / equity¥237mat 2020-12-31dCons.Net assets (5-year summary)
Net assets / equity¥135mat 2019-12-31dCons.Net assets (5-year summary)
Cash and deposits¥1.4bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥1.1bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥1.4bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥1.1bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥865mat 2021-12-31dCons.Cash and cash equivalents
Cash & equivalents¥403mat 2020-12-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥410mat 2019-12-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥238m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥813m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥462m2021-01-01 → 2021-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥125m2020-01-01 → 2020-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥192m2019-01-01 → 2019-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥836m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥511m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥524m2021-01-01 → 2021-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥75m2020-01-01 → 2020-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥361m2019-01-01 → 2019-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥892m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥90m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥523m2021-01-01 → 2021-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥57m2020-01-01 → 2020-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥318m2019-01-01 → 2019-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥82.872023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥103.12022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥94.182021-01-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥83.32020-01-01 → 2020-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥62.32019-01-01 → 2019-12-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥789.4at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥709.96at 2022-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥606.92at 2021-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥193.28at 2020-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥109.98at 2019-12-31dCons.Net assets per share (5-year summary)
Equity ratio29.1%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio35.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.2%at 2021-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio11.5%at 2020-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio6.5%at 2019-12-31dCons.Equity to asset ratio (5-year summary)
ROE11.1%2023-01-01 → 2023-12-31Cons.Rate of return on equity (5-year summary)
ROE15.7%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
ROE23.7%2021-01-01 → 2021-12-31dCons.Rate of return on equity (5-year summary)
ROE54.9%2020-01-01 → 2020-12-31dCons.Rate of return on equity (5-year summary)
ROE79.0%2019-01-01 → 2019-12-31dCons.Rate of return on equity (5-year summary)
Employees425at 2023-12-31Cons.Number of employees
Employees389at 2022-12-31Cons.Number of employees
Employees336at 2021-12-31dCons.Number of employees
Employees267at 2020-12-31dCons.Number of employees
Employees205at 2019-12-31dCons.Number of employees
Revenue¥3.7bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥3.3bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥2.9bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.4bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.0bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income¥75m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥97m2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income¥124m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥150m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥89m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥109m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥120m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥124m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥150m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥78m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥92m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥54m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥78m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥89m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥2.2bnat 2023-12-31StandaloneAssets
Total assets¥1.9bnat 2022-12-31StandaloneAssets
Total assets¥1.6bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥755mat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥604mat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.3bnat 2023-12-31StandaloneLiabilities
Total liabilities¥981mat 2022-12-31StandaloneLiabilities
Net assets / equity¥961mat 2023-12-31StandaloneNet assets
Net assets / equity¥903mat 2022-12-31StandaloneNet assets
Net assets / equity¥811mat 2021-12-31dStandaloneNet assets
Net assets / equity¥204mat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥126mat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.2bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥904mat 2022-12-31StandaloneCash and deposits
EPS (basic)¥50.892023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥60.532022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥37.172021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥63.622020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥72.442019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥636.69at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥591.07at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥530.6at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥166.36at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥102.74at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio42.9%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio47.9%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio52.0%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio27.1%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio20.9%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.3%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE10.8%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE10.7%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE47.3%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE108.9%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,533,100at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,528,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,528,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,228,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued12,280at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees418at 2023-12-31StandaloneNumber of employees
Employees382at 2022-12-31StandaloneNumber of employees
Employees329at 2021-12-31dStandaloneNumber of employees
Employees260at 2020-12-31dStandaloneNumber of employees
Employees199at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2023-01-01 → 2023-12-31¥3m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-12-31−¥80m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-12-31−¥80m
Reconciling Itemsreconcilingsegment assetsat 2023-12-31−¥181m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-12-31−¥24m
Nursing Care Businessreportable segmentcapex2023-01-01 → 2023-12-31¥19m
Nursing Care Businessreportable segmentdepreciation2023-01-01 → 2023-12-31¥29m
Nursing Care Businessreportable segmentemployeesat 2023-12-31394 pure
Nursing Care Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥3.7bn
Nursing Care Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥3.7bn
Nursing Care Businessreportable segmentsegment assetsat 2023-12-31¥2.2bn
Nursing Care Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥101m
Real Estate Businessreportable segmentcapex2023-01-01 → 2023-12-31¥771m
Real Estate Businessreportable segmentdepreciation2023-01-01 → 2023-12-31¥54m
Real Estate Businessreportable segmentemployeesat 2023-12-317 pure
Real Estate Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥604m
Real Estate Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥524m
Real Estate Businessreportable segmentrevenue intersegment2023-01-01 → 2023-12-31¥80m
Real Estate Businessreportable segmentsegment assetsat 2023-12-31¥2.1bn
Real Estate Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥34m
—segment totalcapex2023-01-01 → 2023-12-31¥790m
—segment totaldepreciation2023-01-01 → 2023-12-31¥84m
—segment totalrevenue2023-01-01 → 2023-12-31¥4.3bn
—segment totalrevenue external2023-01-01 → 2023-12-31¥4.3bn
—segment totalrevenue intersegment2023-01-01 → 2023-12-31¥80m
—segment totalsegment assetsat 2023-12-31¥4.3bn
—segment totalsegment profit2023-01-01 → 2023-12-31¥135m
Reconciling Itemsreconcilingdepreciation2022-01-01 → 2022-12-31¥3m
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-12-31−¥80m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-12-31−¥80m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31−¥176m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥59m
Nursing Care Businessreportable segmentcapex2022-01-01 → 2022-12-31¥27m
Nursing Care Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥28m
Nursing Care Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥3.3bn
Nursing Care Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥3.3bn
Nursing Care Businessreportable segmentsegment assetsat 2022-12-31¥1.9bn
Nursing Care Businessreportable segmentsegment profit2022-01-01 → 2022-12-31¥157m
Real Estate Businessreportable segmentcapex2022-01-01 → 2022-12-31¥494m
Real Estate Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥39m
Real Estate Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥837m
Real Estate Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥756m
Real Estate Businessreportable segmentrevenue intersegment2022-01-01 → 2022-12-31¥80m
Real Estate Businessreportable segmentsegment assetsat 2022-12-31¥1.3bn
Real Estate Businessreportable segmentsegment profit2022-01-01 → 2022-12-31¥95m
—segment totalcapex2022-01-01 → 2022-12-31¥521m
—segment totaldepreciation2022-01-01 → 2022-12-31¥66m
—segment totalrevenue2022-01-01 → 2022-12-31¥4.2bn
—segment totalrevenue external2022-01-01 → 2022-12-31¥4.1bn
—segment totalrevenue intersegment2022-01-01 → 2022-12-31¥80m
—segment totalsegment assetsat 2022-12-31¥3.2bn
—segment totalsegment profit2022-01-01 → 2022-12-31¥252m
Nursing Care Businessreportable segmentemployeesat 2023-12-31394 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,209
ItemContextValueUnit
Net cash provided by used in investment activitiesCurrentYearDuration-836328000JPY
Net increase decrease in short term loans payable fin cfPrior1YearDuration150000000JPY
Net increase decrease in short term loans payable fin cfCurrentYearDuration771270000JPY
Proceeds from long term loans payable fin cfPrior1YearDuration400000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration385000000JPY
Repayment of long term loans payable fin cfPrior1YearDuration-635728000JPY
Repayment of long term loans payable fin cfCurrentYearDuration-235819000JPY
Repayments of lease obligations fin cfPrior1YearDuration-4255000JPY
Repayments of lease obligations fin cfCurrentYearDuration-JPY
Purchase of treasury stock fin cfPrior1YearDuration-128000JPY
Purchase of treasury stock fin cfCurrentYearDuration-27995000JPY
Net cash provided by used in financing activitiesPrior1YearDuration-90111000JPY
Net cash provided by used in financing activitiesCurrentYearDuration892455000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration211938000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration294310000JPY
Cash and cash equivalentsPrior2YearInstant865111000JPY
Cash and cash equivalentsPrior1YearInstant1077050000JPY
Cash and cash equivalentsPrior1YearInstant1077050000JPY
Cash and cash equivalentsCurrentYearInstant1371361000JPY
Number of consolidated subsidiariesCurrentYearInstant1
Directors compensations sgaPrior1YearDuration114360000JPY
Directors compensations sgaCurrentYearDuration126210000JPY
Salaries and allowances sgaPrior1YearDuration99717000JPY
Salaries and allowances sgaCurrentYearDuration107867000JPY
Provision for bonuses sgaPrior1YearDuration14036000JPY
Provision for bonuses sgaCurrentYearDuration15435000JPY
Commission fee sgaPrior1YearDuration85096000JPY
Commission fee sgaCurrentYearDuration87786000JPY
Taxes and dues sgaPrior1YearDuration75731000JPY
Taxes and dues sgaCurrentYearDuration91254000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration1327000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration-JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36353-000NursingCareBusinessReportableSegmentsMember3345409000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36353-000RealEstateBusinessReportableSegmentsMember756166000JPY
Revenues from external customersPrior1YearDuration_ReportableSegmentsMember4101575000JPY
Revenues from external customersPrior1YearDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YearDuration4101575000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36353-000NursingCareBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36353-000RealEstateBusinessReportableSegmentsMember80411000JPY
Transactions with other segmentsPrior1YearDuration_ReportableSegmentsMember80411000JPY
Transactions with other segmentsPrior1YearDuration_ReconcilingItemsMember-80411000JPY
Transactions with other segmentsPrior1YearDuration-JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36353-000NursingCareBusinessReportableSegmentsMember3345409000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36353-000RealEstateBusinessReportableSegmentsMember836577000JPY
Net salesPrior1YearDuration_ReportableSegmentsMember4181987000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember-80411000JPY
Net salesPrior1YearDuration4101575000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36353-000NursingCareBusinessReportableSegmentsMember157025000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36353-000RealEstateBusinessReportableSegmentsMember95470000JPY
Operating incomePrior1YearDuration_ReportableSegmentsMember252495000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass